Skip to content
2000
Volume 16, Issue 3
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

The tetracycline-controlled Tet-Off and Tet-On gene expression systems are used to regulate the activity of genes in eukaryotic cells in diverse settings, varying from basic biological research to biotechnology and gene therapy applications. These systems are based on regulatory elements that control the activity of the tetracycline-resistance operon in bacteria. The Tet-Off system allows silencing of gene expression by administration of tetracycline (Tc) or tetracycline-derivatives like doxycycline (dox), whereas the Tet-On system allows activation of gene expression by dox. Since the initial design and construction of the original Tet-system, these bacterium-derived systems have been significantly improved for their function in eukaryotic cells. We here review how a dox-controlled HIV-1 variant was designed and used to greatly improve the activity and dox-sensitivity of the rtTA transcriptional activator component of the Tet-On system. These optimized rtTA variants require less dox for activation, which will reduce side effects and allow gene control in tissues where a relatively low dox level can be reached, such as the brain.

Loading

Article metrics loading...

/content/journals/cgt/10.2174/1566523216666160524144041
2016-06-01
2025-05-24
Loading full text...

Full text loading...

/content/journals/cgt/10.2174/1566523216666160524144041
Loading

  • Article Type:
    Research Article
Keyword(s): Doxycycline; Gene expression; rtTA; Tet-Off system; Tet-On system; TetR; Transcription regulation; tTA
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test